687 related articles for article (PubMed ID: 32384763)
1. Identifying the Therapeutic Significance of Mesenchymal Stem Cells.
Mishra VK; Shih HH; Parveen F; Lenzen D; Ito E; Chan TF; Ke LY
Cells; 2020 May; 9(5):. PubMed ID: 32384763
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus.
Zhu L; Wang S; Qu J; Hui Z; Kan C; Hou N; Sun X
Cell Reprogram; 2022 Dec; 24(6):329-342. PubMed ID: 35877064
[TBL] [Abstract][Full Text] [Related]
3. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
Front Immunol; 2018; 9():1078. PubMed ID: 29892282
[TBL] [Abstract][Full Text] [Related]
4. Concise Review: Mesenchymal Stem Cells: From Roots to Boost.
Andrzejewska A; Lukomska B; Janowski M
Stem Cells; 2019 Jul; 37(7):855-864. PubMed ID: 30977255
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation effect of mesenchymal stem cells in islet transplantation.
Shrestha M; Nguyen TT; Park J; Choi JU; Yook S; Jeong JH
Biomed Pharmacother; 2021 Oct; 142():112042. PubMed ID: 34403963
[TBL] [Abstract][Full Text] [Related]
6. NK and MSCs crosstalk: the sense of immunomodulation and their sensitivity.
Casado JG; Tarazona R; Sanchez-Margallo FM
Stem Cell Rev Rep; 2013 Apr; 9(2):184-9. PubMed ID: 23397451
[TBL] [Abstract][Full Text] [Related]
7. In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells.
Chaudhary D; Trivedi RN; Kathuria A; Goswami TK; Khandia R; Munjal A
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):59-68. PubMed ID: 29485014
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.
Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y
Nat Rev Nephrol; 2018 Aug; 14(8):493-507. PubMed ID: 29895977
[TBL] [Abstract][Full Text] [Related]
10. Impact of Diabetes Mellitus on Human Mesenchymal Stromal Cell Biology and Functionality: Implications for Autologous Transplantation.
Mahmoud M; Abu-Shahba N; Azmy O; El-Badri N
Stem Cell Rev Rep; 2019 Apr; 15(2):194-217. PubMed ID: 30680660
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.
Lee DK; Song SU
Cell Immunol; 2018 Apr; 326():68-76. PubMed ID: 28919171
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.
Wu X; Jiang J; Gu Z; Zhang J; Chen Y; Liu X
Stem Cell Res Ther; 2020 Aug; 11(1):345. PubMed ID: 32771052
[TBL] [Abstract][Full Text] [Related]
14. Adipogenic Differentiation of Mesenchymal Stem Cells Alters Their Immunomodulatory Properties in a Tissue-Specific Manner.
Munir H; Ward LSC; Sheriff L; Kemble S; Nayar S; Barone F; Nash GB; McGettrick HM
Stem Cells; 2017 Jun; 35(6):1636-1646. PubMed ID: 28376564
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
Huang Y; Wu Q; Tam PKH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421
[TBL] [Abstract][Full Text] [Related]
16. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
[TBL] [Abstract][Full Text] [Related]
17. Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases.
Ryu JS; Jeong EJ; Kim JY; Park SJ; Ju WS; Kim CH; Kim JS; Choo YK
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171878
[TBL] [Abstract][Full Text] [Related]
18. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to be Aware of.
Saeedi M; Nezhad MS; Mehranfar F; Golpour M; Esakandari MA; Rashmeie Z; Ghorbani M; Nasimi F; Hoseinian SN
Curr Pharm Biotechnol; 2021; 22(2):200-215. PubMed ID: 32895040
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus.
Mabed M; Shahin M
Curr Stem Cell Res Ther; 2012 May; 7(3):179-90. PubMed ID: 22023626
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
